Financhill
Back

Agios Pharmaceuticals Quote, Financials, Valuation and Earnings

A 10,000% Dividend?!?

Watch the short presentation by clicking here.
Sell
13

AGIO
Agios Pharmaceuticals

Last Price:
46.05
Seasonality Move:
12.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE

Agios Pharmaceuticals Price Quote

$46.05
+0.03 (+-5.32%)
(Updated: December 11, 2024 at 5:04 AM ET)

Agios Pharmaceuticals Key Stats

Sell
13
Agios Pharmaceuticals (AGIO) is a Sell

Day range:
$44.35 - $51.27
52-week range:
$20.96 - $62.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
79.64
P/B ratio:
1.61%

Volume:
2.3M
Avg. volume:
816.8K
1-year change:
108.71%
Market cap:
$2.6B
Revenue:
$26.8M
EPS:
$11.36

How Much Does Agios Pharmaceuticals Make?

Is Agios Pharmaceuticals Growing As A Company?

  • What Is Agios Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.21%
  • What Is Agios Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Agios Pharmaceuticals Stock Price Performance

What Is Agios Pharmaceuticals 52-Week High & Low?

Agios Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Agios Pharmaceuticals?

Is Agios Pharmaceuticals Cash Flow Positive?

  • What Is AGIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$329.2M
  • What Is Agios Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.4M
  • What Is Agios Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $508.1M

Agios Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AGIO return on invested capital is 71.3%
  • What Is Agios Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 62.91%
  • What Is AGIO Return On Equity?
    ROE is a measure of profitability and is 71.3%

Agios Pharmaceuticals Earnings Date & Stock Price

Agios Pharmaceuticals Competitors

Agios Pharmaceuticals Dividend Yield

Agios Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -118.52%
Revenue: 21.15% -5.66%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 56.50
Upside from Last Price: 22.77%

Major Shareholders

  • How many AGIO shares are owned by institutional investors?
    91.8M AGIO shares are owned by institutional investors
  • How many AGIO shares are owned by insiders?
    1.3M AGIO shares are owned by insiders